TY - JOUR A1 - Lisowska, Justyna A1 - Rödel, Claudia Jasmin A1 - Manet, Sandra A1 - Miroshnikova, Yekaterina A. A1 - Boyault, Cyril A1 - Planus, Emmanuelle A1 - De Mets, Richard A1 - Lee, Hsiao-Hui A1 - Destaing, Olivier A1 - Mertani, Hichem A1 - Boulday, Gwenola A1 - Tournier-Lasserve, Elisabeth A1 - Balland, Martial A1 - Abdelilah-Seyfried, Salim A1 - Albiges-Rizo, Corinne A1 - Faurobert, Eva T1 - The CCM1-CCM2 complex controls complementary functions of ROCK1 and ROCK2 that are required for endothelial integrity JF - Journal of cell science N2 - Endothelial integrity relies on a mechanical crosstalk between intercellular and cell-matrix interactions. This crosstalk is compromised in hemorrhagic vascular lesions of patients carrying loss-of-function mutations in cerebral cavernous malformation (CCM) genes. RhoA/ROCK-dependent cytoskeletal remodeling is central to the disease, as it causes unbalanced cell adhesion towards increased cell-extracellular matrix adhesions and destabilized cell-cell junctions. This study reveals that CCM proteins directly orchestrate ROCK1 and ROCK2 complementary roles on the mechanics of the endothelium. CCM proteins act as a scaffold, promoting ROCK2 interactions with VE-cadherin and limiting ROCK1 kinase activity. Loss of CCM1 (also known as KRIT1) produces excessive ROCK1-dependent actin stress fibers and destabilizes intercellular junctions. Silencing of ROCK1 but not ROCK2 restores the adhesive and mechanical homeostasis of CCM1 and CCM2-depleted endothelial monolayers, and rescues the cardiovascular defects of ccm1 mutant zebrafish embryos. Conversely, knocking down Rock2 but not Rock1 in wild-type zebrafish embryos generates defects reminiscent of the ccm1 mutant phenotypes. Our study uncovers the role of the CCM1-CCM2 complex in controlling ROCK1 and ROCK2 to preserve endothelial integrity and drive heart morphogenesis. Moreover, it solely identifies the ROCK1 isoform as a potential therapeutic target for the CCM disease. KW - CCM KW - ROCK KW - Endothelial integrity KW - Mechanotransduction Y1 - 2018 U6 - https://doi.org/10.1242/jcs.216093 SN - 0021-9533 SN - 1477-9137 VL - 131 IS - 15 PB - Company biologists LTD CY - Cambridge ER -